Correlation between clinicopathological characteristics and the clinical prognosis of patients with gastroenteropancreatic neuroendocrine tumors

被引:1
|
作者
Fan, Dongwei [1 ]
Li, Xuanhe [2 ]
Yu, Yousheng [1 ]
Wang, Xingliang [1 ]
Fang, Jun [1 ]
Huang, Cheng [1 ,3 ]
机构
[1] West Anhui Hlth Vocat Coll, Affiliated Hosp, Dept Gen Surg, Luan 237000, Anhui, Peoples R China
[2] Bengbu Med Coll, Affiliated Hosp 1, Dept Surg Oncol, Bengbu 233000, Anhui, Peoples R China
[3] West Anhui Hlth Vocat Coll, Affiliated Hosp, Dept Gen Surg, 73 Mozitan Rd, Luan 237000, Anhui, Peoples R China
关键词
gastroenteropancreatic neuroendocrine tumor; clinical and pathological characteristics; prognostic factors; SERUM CHROMOGRANIN-A; CONSENSUS GUIDELINES; DIAGNOSIS; MANAGEMENT; CLASSIFICATION; RATIONALE; NEOPLASMS; FEATURES; TRACT;
D O I
10.3892/mco.2023.2681
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) are one of the most common types of NETs, accounting for 65-75% of all NETs. However, epidemiological characteristics of patients with GEP-NETs in China are still lacking. The present retrospective study aimed to investigate the local epidemiology of GEP-NETs and assess the prognostic factors in China. The data of 267 patients with GEP-NETs who were admitted to the First Affiliated Hospital of Bengbu Medical College (Bengbu, China) and the Affiliated Hospital of West Anhui Health Vocational College (Lu'an, China) were retrospectively reviewed. The clinical and pathological characteristics of the patients, as well as follow-up information, were collected, and the 5-year survival rate was calculated. Kaplan-Meier curves and log-rank analysis were used to analyze the prognostic factors. The stomach (100/267; 37.5%) was the most common site of GEP-NETs and the liver (25/39; 64.1%) was the most common metastatic site. A total of 166 (62.2%) and 219 (82.0%) patients had positive results for chromogranin A (CgA) and synaptophysin (Syn), respectively. The percentage of patients with tumor grade G1, G2 and G3 was 33.3, 21.0 and 45.7%, respectively. The 5-year overall survival rate was 79.7%, and the age, tumor site, distant metastasis and tumor grading upon diagnosis were all prognostic factors. In conclusion, the present case series investigated the epidemiology and prognostic factors of GEP-NETs in China. CgA and Syn could be used as diagnostic markers for NETs and the stomach was the most common primary tumor site. Lymph node metastasis, tumor site, distant metastasis and tumor grading were important prognostic factors.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Clinical Features and Quality of Life in Patients with Gastroenteropancreatic Neuroendocrine Tumors from Chile
    Carrillo, D.
    Munoz-Anguita, G.
    Madison, A.
    Retamal, I
    Pinto, M.
    Bravo, L.
    Cordova Delgado, M.
    Munoz-Medel, M.
    Garrido, M.
    NEUROENDOCRINOLOGY, 2020, 110 : 65 - 65
  • [32] Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumors
    Paragliola, Rosa Maria
    Prete, Alessandro
    Papi, Giampaolo
    Torino, Francesco
    Corsello, Andrea
    Pontecorvi, Alfredo
    Corsello, Salvatore Maria
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 3459 - 3470
  • [33] Gastroenteropancreatic neuroendocrine tumors: Epigenetic landscape and clinical implications
    McMurry, Hannah S.
    Del Rivero, Jaydira
    Chen, Emerson Y.
    Kardosh, Adel
    Lopez, Charles D.
    Pegna, Guillaume J.
    CURRENT PROBLEMS IN CANCER, 2024, 52
  • [34] Clinical Characteristics and Prognostic Factors of Gastroenteropancreatic Neuroendocrine Tumors: A Single Center Experience in China
    Hu, Han-kui
    Ke, Neng-wen
    Li, Ang
    Du, Xiao-jiong
    Guo, Qiang
    Hu, Wei-ming
    HEPATO-GASTROENTEROLOGY, 2015, 62 (137) : 178 - 183
  • [35] Pulmonary neuroendocrine tumors: study of 266 cases focusing on clinicopathological characteristics, immunophenotype, and prognosis
    Zhang, Shuwen
    Chen, Jingjing
    Zhang, Rui
    Xu, Liqin
    Wang, Yan
    Yuan, Zaixin
    Hou, Xiaohui
    Feng, Jian
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (03) : 1063 - 1077
  • [36] Pulmonary neuroendocrine tumors: study of 266 cases focusing on clinicopathological characteristics, immunophenotype, and prognosis
    Shuwen Zhang
    Jingjing Chen
    Rui Zhang
    Liqin Xu
    Yan Wang
    Zaixin Yuan
    Xiaohui Hou
    Jian Feng
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 1063 - 1077
  • [37] Microvessel Density and Prognosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETS)
    Soares, C.
    Bettencourt, H.
    Preto, J.
    Soares, P.
    Pinto-de-Sousa, J.
    Taveira Gomes, A.
    Costa Maia, J.
    Manuel Lopes, J.
    NEUROENDOCRINOLOGY, 2011, 94 : 11 - 11
  • [38] Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors: Frequency, Treatment and Prognosis
    Madani, A.
    Thomassen, I
    Van Gestel, Y.
    Van der Bilt, J.
    Haak, H.
    De Hingh, I
    Lemmens, V
    NEUROENDOCRINOLOGY, 2016, 103 : 32 - 32
  • [39] CLINICOPATHOLOGICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH SMALL INTESTINAL STROMAL TUMORS
    Chiu, Yi-Chun
    Lin, Jui-Wei
    Changchien, Chi Sin
    Huang, Chao-Chen
    Liu, Shang-Yun
    Yi, Li-Na
    Chiu, King-Wah
    Wu, Keng-Liang
    Chen, Yen-Yang
    Chou, Fong-Fu
    Hu, Tsung-Hui
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2005, 104 (12) : 905 - 912
  • [40] Growth behaviour and prognosis of patients with untreated metastatic or locally advanced gastroenteropancreatic (GEP) neuroendocrine tumors
    Badihian, T
    Sprenger, A
    Mueller, HH
    Klose, KJ
    Arnold, R
    GASTROENTEROLOGY, 2004, 126 (04) : A391 - A391